148 related articles for article (PubMed ID: 8210624)
1. [Plasma fibronectin in chronic liver diseases].
Soresi M; Di Martino D; Montalto G; Carroccio A; Ruggeri MI; Bascone F; Ippolito S; Notarbartolo A
Recenti Prog Med; 1993 Sep; 84(9):602-7. PubMed ID: 8210624
[TBL] [Abstract][Full Text] [Related]
2. [Plasma fibronectin in chronic liver disease--marker of fibrosis?].
Simon K; Zalewska M; Gładysz A; Rotter K; Piszko P; Głowacki A
Przegl Lek; 1995; 52(4):129-32. PubMed ID: 7638358
[TBL] [Abstract][Full Text] [Related]
3. [Changes in plasma vitronectin, fibronectin, and serum laminin P1 levels and immunohistochemical study of vitronectin in the liver of patients with chronic liver diseases].
Tomihira M
Fukuoka Igaku Zasshi; 1991 Jan; 82(1):21-30. PubMed ID: 1708742
[TBL] [Abstract][Full Text] [Related]
4. Tumour necrosis factor-alpha levels in hepatitis B virus-related chronic active hepatitis and liver cirrhosis and its relationship to Knodell and Child-Pugh scores.
Kiki I; Yilmaz O; Erdem F; Gundogdu M; Demircan B; Bilici M
Int J Clin Pract; 2006 Sep; 60(9):1075-9. PubMed ID: 16939549
[TBL] [Abstract][Full Text] [Related]
5. Plasma levels of fibronectin in patients with chronic viral and alcoholic liver disease.
Grieco A; Matera A; Di Rocco P; Marcoccia S; Giancaterini A; Alfei B; Addolorato G; Varlese F; Gasbarrini G
Hepatogastroenterology; 1998; 45(23):1731-6. PubMed ID: 9840137
[TBL] [Abstract][Full Text] [Related]
6. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis, and its relationship with circulating thrombocyte counts.
Koruk M; Onuk MD; Akçay F; Savas MC
Hepatogastroenterology; 2002; 49(48):1645-8. PubMed ID: 12397754
[TBL] [Abstract][Full Text] [Related]
7. Simple blood tests can predict compensated liver cirrhosis in patients with chronic hepatitis C.
Luo JC; Hwang SJ; Chang FY; Chu CW; Lai CR; Wang YJ; Lee PC; Tsay SH; Lee SD
Hepatogastroenterology; 2002; 49(44):478-81. PubMed ID: 11995477
[TBL] [Abstract][Full Text] [Related]
8. [Factors influencing the effect of ursodeoxycholic acid therapy in chronic hypertransaminasemia].
Buongiorno G; Quaranta GM; Guerra V; Misciagna G; Manghisi OG
Recenti Prog Med; 1992 May; 83(5):298-302. PubMed ID: 1439111
[TBL] [Abstract][Full Text] [Related]
9. Serum iron parameters in patients with alcoholic and chronic cirrhosis and hepatitis.
Jurczyk K; Wawrzynowicz-Syczewska M; Boroń-Kaczmarska A; Sych Z
Med Sci Monit; 2001; 7(5):962-5. PubMed ID: 11535942
[TBL] [Abstract][Full Text] [Related]
10. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
[TBL] [Abstract][Full Text] [Related]
11. Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis.
Cicognani C; Malavolti M; Morselli-Labate AM; Zamboni L; Sama C; Barbara L
Arch Intern Med; 1997 Apr; 157(7):792-6. PubMed ID: 9125012
[TBL] [Abstract][Full Text] [Related]
12. [Blood amino acids in chronic HBsAg positive liver disease].
De Marco F; Palmieri G; Capuano G; Gentile R; Nardone G; Parrilli G; Prantera T; Budillon G
Boll Soc Ital Biol Sper; 1983 Oct; 59(10):1576-81. PubMed ID: 6661322
[TBL] [Abstract][Full Text] [Related]
13. [The plasma levels of urokinase plasminogen activator and urokinase plasminogen activator receptor and plasminogen activator inhibitor-1 in patients with different stages of liver cirrhosis following chronic hepatitis B].
Wu XR; Wang Q; Shi SS; Lu MH; Guo WD
Zhonghua Gan Zang Bing Za Zhi; 2004 Feb; 12(2):82-4. PubMed ID: 14980106
[TBL] [Abstract][Full Text] [Related]
14. Profiles of plasma amino acids in fasted patients with various liver diseases.
Fujinami S; Hijikata Y; Shiozaki Y; Sameshima Y
Hepatogastroenterology; 1990 Dec; 37 Suppl 2():81-4. PubMed ID: 2083940
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostic importance of fibronectin in chronic liver diseases].
Golubović M; Majkić-Singh N; Marković S; Sumarac Z; Obradović I
Med Pregl; 1999; 52(1-2):35-8. PubMed ID: 10352502
[TBL] [Abstract][Full Text] [Related]
16. [Biochemical markers of fibrosis in chronic hepatitis and liver cirrhosis of viral origin].
Kozłowska J; Łoch T; Jabłońska J; Cianciara J
Przegl Epidemiol; 2001; 55(4):451-8. PubMed ID: 11921731
[TBL] [Abstract][Full Text] [Related]
17. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease.
Bjøro K; Brandsaeter B; Wiencke K; Bjøro T; Godang K; Bollerslev J; Schrumpf E
Scand J Gastroenterol; 2003 Mar; 38(3):320-7. PubMed ID: 12737449
[TBL] [Abstract][Full Text] [Related]
18. [Study on the influence factors of the serum fibrosis markers].
Cai WM; Tao J; Weng HL; Liu RH
Zhonghua Gan Zang Bing Za Zhi; 2003 Jan; 11(1):23-5. PubMed ID: 12546736
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of oxidant stress in Wilson's disease and non-Wilsonian chronic liver disease in childhood.
Dalgiç B; Sönmez N; Biberoğlu G; Hasanoğlu A; Erbaş D
Turk J Gastroenterol; 2005 Mar; 16(1):7-11. PubMed ID: 16252181
[TBL] [Abstract][Full Text] [Related]
20. Fibronectin levels in chronic viral hepatitis and response of this protein to interferon therapy.
Kandemir O; Polat G; Sahin E; Bagdatoglu O; Camdeviren H; Kaya A
Hepatogastroenterology; 2004; 51(57):811-4. PubMed ID: 15143922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
